Litigation Details for Halozyme, Inc. v. Lee (E.D. Va. 2016)
✉ Email this page to a colleague
Halozyme, Inc. v. Lee (E.D. Va. 2016)
Docket | ⤷ Try a Trial | Date Filed | 2016-12-18 |
Court | District Court, E.D. Virginia | Date Terminated | 2018-07-31 |
Cause | 35:145 Patent Non-Infringement- Patent Applicant is Dissatisfied with PTO Decision | Assigned To | Claude M. Hilton |
Jury Demand | None | Referred To | John F. Anderson |
Parties | HALOZYME, INC. | ||
Patents | 7,767,429; 7,829,081; 7,846,431; 7,871,607 | ||
Attorneys | Dennis Carl Barghaan , Jr. | ||
Firms | McDermott Will & Emery LLP - DC | ||
Link to Docket | External link to docket |
Biologic Drugs cited in Halozyme, Inc. v. Lee
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Halozyme, Inc. v. Lee (E.D. Va. 2016)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2016-12-18 | 1 | non-statutory obviousness-type double patenting over U.S. Patent Nos. 7,767,429 (claims 9 and 10), 7,846,431 …to receive a patent against Defendant, MICHELLE K, LEE, Director, United States Patent and Trademark ….S. Patent No. 5,766,897, issued June 16, 1998 (“Braxton”); and (c) Thompson et al., U.S. Patent No. …Property ) and Director of the United States Patent and ) Trademark Office, …pursuant to 35 U.S.C. § 145 by the assignee of U.S. Patent Application Serial No. 11/238,171 (“the ’171 Application | External link to document | |
2017-11-12 | 143 | statutory obviousness-type double patenting over U.S. Patent Nos. 7,767,429 (Claims 9 and 10), 7,846,431…of a patent . . . by prohibiting the issuance of the claims in a second patent not patentably distinct…the applicant for patent or (2) a patent granted on an application for patent by another filed…Claim 264 and the ‘429 Patent Claims 9 and 10 Are Patentably Distinct. ...........… The Pending Claims are patently distinct from Claim 6 of the ’081 Patent. [Flamion Test.] | External link to document | |
2018-07-31 | 173 | of U.S. Patent No. 7,767,429 ("the M29 patent") in…seeking reversal of a patent rejection decision issued by the United States Patent and Trademark Office…challenging a final decision issued by the USPTO's Patent Trial and Appeal Board (the "Board")…affirmed the rejections of claims in U.S. Patent Application 11/238,171 ("…2016 31 July 2018 1:16-cv-01580 830 Patent None District Court, E.D. Virginia | External link to document | |
2018-10-23 | 186 | U.S. Patent No. 7,767,429 ("the M29 patent") in view of the U.S. Patent No. …lancu's. Under Secretary of the United States Patent and Trademark Office ("USPTO"), motion…challenging a final decision issued by the USPTC s Patent Trial and Appeal Board (the ^'Board"…the rejections of claims in U.S. Patent Application 11/238,171 ("the … 5,766,897 ("Braxton") and U.S. Patent No. 6,552,170 ("Thompson" | External link to document | |
2017-09-08 | 96 | Exhibit Ex. 1 to M. Kim Decl. | double patenting over Claims 9 and 10 of the U.S. Patent No. 7,767,429 (the “’429 Patent”) (A1719…obviousness-type double patenting rejections of the Pending Claims over U.S. Patent Nos. 7,767,429 titled “Soluble…obviousness-type double patenting rejections of the Pending Claims over U.S. Patent Nos. 7,767,429 (claims 9 and…obviousness-type double patenting rejections of the Pending Claims over U.S. Patent Nos. 7,767,429 (claims 9 and…) the Pending Claims are patentable distinct from U.S. Patent Nos. 7,767,429 (claims 9 and | External link to document |
2017-09-08 | 97 | of claims 9 and 10 of U.S. Patent No. 7,767,429 in view of U.S. Patent Nos. 5,766,897 (“Braxton”) and…on Claims 9 and 10 of U.S. Patent No. 7,767,429 in View of Braxton and Thompson…CLAIMS BASED ON CLAIMS 9 AND 10 OF U.S. PATENT NO. 7,767,429 IN VIEW OF BRAXTON AND THOMPSON…claims in a second patent not patentably distinct from the claims of the first patent.” Eli Lilly, 689 …reference patent] and specified dosages in the [patent at- issue] [ ] are, in combination, patentably distinct | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |